about
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic diseaseGhrelin immunoreactivity in human plasma is suppressed by somatostatinInsulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose loadAcute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young men.Impact of growth hormone receptor blockade on substrate metabolism during fasting in healthy subjects.Acromegaly according to the Danish National Registry of Patients: how valid are ICD diagnoses and how do patterns of registration affect the accuracy of registry data?Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis.Validity of the International Classification of Diseases, 10th revision discharge diagnosis codes for hyponatraemia in the Danish National Registry of Patients.Serum proteome changes in acromegalic patients following transsphenoidal surgery: novel biomarkers of disease activity.Epidemiology of Cushing's syndrome.Evaluation of functional erythropoietin receptor status in skeletal muscle in vivo: acute and prolonged studies in healthy human subjectsMortality in Cushing's syndrome: a systematic review and meta-analysis.Safety aspects of growth hormone replacement in adults.Resveratrol in metabolic health: an overview of the current evidence and perspectives.Metabolic effects of GH: a rationale for continued GH treatment of GH-deficient adults after cessation of linear growth.Short-term tools to measure responsiveness to growth hormone replacement.Fasting increases human skeletal muscle net phenylalanine release and this is associated with decreased mTOR signalingSerum proteomic changes after randomized prolonged erythropoietin treatment and/or endurance training: detection of novel biomarkers.Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids.Somatropin and glucose homeostasis: considerations for patient management.Novel serum protein biomarkers indicative of growth hormone doping in healthy human subjectsHigh-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.Effects of growth hormone on glucose and fat metabolism in human subjects.Ghrelin- and GH-induced insulin resistance: no association with retinol-binding protein-4.Insulin resistance after a 72-h fast is associated with impaired AS160 phosphorylation and accumulation of lipid and glycogen in human skeletal muscle.Novel serum biomarkers for erythropoietin use in humans: a proteomic approach.Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.Effects of GH in human muscle and fat.Expression of leptin receptor isoforms and effects of leptin on the proliferation and hormonal secretion in human pituitary adenomas.Management of endocrine disease: Mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis.Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis.Glucose and Fat Metabolism in Acromegaly: From Mice Models to Patient Care.Identification of new biomarkers of low-dose GH replacement therapy in GH-deficient patients.Hormone and Cytokine Responses to Repeated Endotoxin Exposures-No Evidence of Endotoxin Tolerance After 5 Weeks in Humans.Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery.Impact of GH administration on athletic performance in healthy young adults: A systematic review and meta-analysis of placebo-controlled trials.Impact of fasting on growth hormone signaling and action in muscle and fat.Systemic glucocorticoid use in Denmark: a population-based prevalence study.Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.Fuel metabolism in growth hormone-deficient adults.
P50
Q26824349-D3CEEF40-20CA-40A1-8822-7D315F999C77Q28611513-34FC3DFC-8EEE-4CCE-8302-43503B367386Q28740507-7F6A821D-0B2B-4414-A521-4680EAD29244Q30353107-2035B135-6D04-4843-8D29-12FCFFADC9E6Q30434315-C1786F83-9745-4749-A6C1-7EF08FE7176AQ30850542-1F7C3324-ED61-47BC-92E0-82C55221B423Q33514258-B190876F-4E91-4085-B270-D1ABCCA8F9FBQ33569596-BF08BE25-B407-4921-A4ED-78B65BBF6D75Q33817041-BD60AECB-7215-4D55-9A03-F60FEA0995DDQ34137130-7E36A9FC-4157-4572-8706-E0C8158C0954Q34182011-AE3F97A3-560E-448F-B8B0-BBD06D558F70Q34258274-3F167CD9-674D-497F-A858-0BA0D855E47FQ34319029-C4BDCC52-3B8B-4CCF-B18D-A4745A8BF4E5Q34357570-3FF22BB8-38E7-4A05-9D9A-3ED3CA438FF8Q34389804-9695F3E3-275F-43C2-B07B-AEC2E4F23CF8Q34422145-015BA6DA-04B9-4546-BF60-0993BC2899B2Q35206436-9420A945-64FA-4C8B-91D5-6F4CBEE5CD37Q35560616-CC561969-FF5C-4723-9CA7-5BF0FF7ACDE7Q36068069-51892803-71A2-4C42-AB9C-24CAA4AB8985Q36084162-0FC344DF-5038-4C8E-9FDC-82F28C17B72AQ36453050-0876F1BE-4F3F-4B73-AE7A-A66E7F0F8F6EQ36720635-8CB001B5-D7B6-4DE9-AD87-70E8B7171EFBQ36751006-E18BA9D1-835C-4591-AEEE-41953087FE93Q36928023-B9A66470-8FAF-4664-9B7F-65D48913C441Q37148896-83D06983-FB12-43EA-9967-A0DB21681CDCQ37202283-81F70345-7EDE-40DC-99C9-DA04BC412667Q37400457-2372EBEA-6B68-4774-A5CE-B88123D3C2CAQ37630396-7C116F11-3B13-445B-8DDD-8738195A15CBQ38338302-6F99DDCD-F4F6-42A3-8DFE-361C7D261293Q38365739-FC100F3E-C889-460D-BF88-17BA1130C757Q38406890-9D444B74-982B-486C-8F6D-6B7CA28CEFBAQ38449781-96D8EAAE-2E34-4258-AD8F-BD5C7FA7CA79Q38893130-DE4ECAC2-9A1E-4A6E-A341-7180A6DE87ACQ39015952-CB20E1A0-37CA-4717-A3C4-75DE0AAAF81AQ39280506-648FB1A8-6078-4382-84CB-6A917C795D9EQ39313264-3C37C16D-EB7C-4F76-B7FC-E8C6CFD0E299Q40020302-489B754A-EDE7-489B-AC89-5BB779ECA991Q40181753-77FD37B2-3A23-41F2-A6E6-EC519303E4CBQ40265810-0EB3BF04-9A28-4E81-B8DA-F90738665FE0Q40369380-FDD47D7A-7263-47D4-98F4-5B9A7585CA5A
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jens Otto Lunde Jørgensen
@ast
Jens Otto Lunde Jørgensen
@en
Jens Otto Lunde Jørgensen
@es
Jens Otto Lunde Jørgensen
@nl
Jens Otto Lunde Jørgensen
@sl
type
label
Jens Otto Lunde Jørgensen
@ast
Jens Otto Lunde Jørgensen
@en
Jens Otto Lunde Jørgensen
@es
Jens Otto Lunde Jørgensen
@nl
Jens Otto Lunde Jørgensen
@sl
altLabel
Jens Otto Lunde Jorgensen
@en
prefLabel
Jens Otto Lunde Jørgensen
@ast
Jens Otto Lunde Jørgensen
@en
Jens Otto Lunde Jørgensen
@es
Jens Otto Lunde Jørgensen
@nl
Jens Otto Lunde Jørgensen
@sl
P1006
P214
P244
P1006
P106
P1153
8081653500
P21
P213
0000 0000 3097 3373
P214
P244
P31
P496
0000-0001-7408-1526
P735
P7859
lccn-n96800023